Bionano retires $20M convertible debentures, eliminates secured debt

Bionano Genomics fully retired all outstanding Senior Secured Convertible Debentures using cash on hand, eliminating all secured debt obligations and asset liens. The move removes financial constraints and provides greater operational flexibility for the company to focus on commercial growth of its optical genome mapping solutions.